Austria vs Slovenia: Life science patents granted, by technology
Austria
2 patents
in 2023
Slovenia
1 patents
in 2023
Austria rank
52nd
Slovenia rank
55th
Life science patents granted, by technology over time
- Austria
- Slovenia
How they compare
Austria currently reports 2 patents against 1 patents in Slovenia, a difference of 1 patents.
That makes Austria's figure about 2.0 times Slovenia's.
The two have swapped places 8 times across 31 shared years of data; in 1992 it was Austria ahead.
Austria ranks 52nd and Slovenia ranks 55th of 65 countries.
Across the 4 decades both report, Austria averaged higher in 2 and Slovenia in 2.
Head to head by decade
| Decade | Austria | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 32.25 patents | 59 patents | 26.75 patents | Slovenia |
| 2000s | 18.2 patents | 18 patents | 0.2 patents | Austria |
| 2010s | 6.4 patents | 4.4 patents | 2 patents | Austria |
| 2020s | 1.33 patents | 1.67 patents | 0.3333 patents | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Austria or Slovenia?
- Austria, at 2 patents against 1 patents in Slovenia as of 2023.
- What is the difference in life science patents granted, by technology between Austria and Slovenia?
- 1 patents, with Austria ahead.
- How many years of comparable data are there for Austria and Slovenia?
- 31 years are reported by both, from 1992 to 2023.
- How do Austria and Slovenia rank globally for life science patents granted, by technology?
- Austria ranks 52nd and Slovenia ranks 55th of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) β processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.